Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Reported side effects Mild local irritation or discomfort at the injection site Headache (typically mild and short-lived) Nausea or dizziness in some patients Sweating Mild fever more commonly reported in post-stroke use, generally manageable with standard antipyretics Contraindications Cerebrolysin is not recommended for individuals with: Active epilepsy or seizure disorders Severe renal (kidney) impairment Known hypersensitivity to any component of the formulation Note: A 2023 Cochrane review noted a potentially higher rate of spontaneous adverse events in some stroke trial subgroups
Extranuclear partners of androgen receptor: at the crossroads of proliferation, migration, and neuritogenesis
Utilises the highly vascular nasal mucosa
Such vigilance ensures the ongoing effectiveness of GLP-1 therapy
US$ 25.92
US$ 29.15
US$ 21.72
US$ 24.44
